Evommune Inc.
EVMN | NYSE
$6.13
-$0.60 (-8.92%)
Nov 2, 2026, 12:49 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
PE Ratio | -7.85 | -8.91 | -17.90 |
PEG Ratio | 1.98 | -0.09 | n/a |
PS Ratio | 41.51 | 86.92 | 121.69 |
PB Ratio | 2.63 | -4.22 | -7.83 |
P/FCF Ratio | -7.04 | -10.44 | -20.22 |
P/OCF Ratio | -7.06 | -10.46 | -20.30 |
OCF/S Ratio | -588.01 | -831.36 | -599.40 |
Debt / Equity Ratio | 0.01 | -1.34 | -1.94 |
Quick Ratio | 8.57 | 2.64 | 11.67 |
Current Ratio | 8.57 | 2.64 | 11.67 |
Asset Turnover | 0.06 | 0.09 | 0.06 |
Interest Coverage | n/a | -2.06K | -652.59 |
Return on Equity | -33.50% | 46.32% | 43.82% |
Return on Assets | -30.62% | -87.84% | -41.40% |
Return on Invested Capital | -39.05% | -142.62% | -49.70% |
Dividend Yield | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a |
Gross Profit Margin | 100% | 81.61% | 80% |
Net Profit Margin | -529.77% | -954.40% | -681.06% |
Pretax Profit Margin | -529.77% | -954.40% | -681.06% |
Operating Profit Margin | -623.62% | -1K% | -757% |
FCF Margin | -589.82% | -832.61% | -601.76% |
EBITDA Margin | -519.08% | -935.53% | -659.90% |
Add to Watchlist
Select watchlists to add or remove EVMN